• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Predictors of survival among older adults with ependymoma.老年人室管膜瘤患者的生存预测因素。
J Neurooncol. 2012 Mar;107(1):183-9. doi: 10.1007/s11060-011-0730-2. Epub 2011 Sep 28.
2
Predictors of survival in patients with spinal ependymoma.脊髓室管膜瘤患者生存的预测因素。
Neurol Res. 2015 Jul;37(7):650-5. doi: 10.1179/1743132815Y.0000000041. Epub 2015 Apr 28.
3
Predictors of survival among pediatric and adult ependymoma cases: a study using Surveillance, Epidemiology, and End Results data from 1973 to 2007.儿童和成人室管膜瘤病例生存预测因素:一项基于 1973 年至 2007 年监测、流行病学和最终结果数据的研究。
Neuroepidemiology. 2012;39(2):116-24. doi: 10.1159/000339320. Epub 2012 Jul 28.
4
Supratentorial hemispheric ependymomas: an analysis of 109 adults for survival and prognostic factors.幕上脑半球室管膜瘤:109 例成人患者的生存分析及预后因素。
J Neurosurg. 2016 Aug;125(2):410-8. doi: 10.3171/2015.7.JNS151187. Epub 2016 Jan 8.
5
Survival Factors in 1580 Adults with Spinal Ependymoma: Insights from a Multicenter Oncology Database.1580 例脊髓室管膜瘤成人患者的生存因素:多中心肿瘤数据库的启示。
World Neurosurg. 2024 Oct;190:e920-e930. doi: 10.1016/j.wneu.2024.08.036. Epub 2024 Aug 12.
6
Treatment and survival of supratentorial and posterior fossa ependymomas in adults.成人幕上和后颅窝室管膜瘤的治疗与生存情况
J Clin Neurosci. 2016 Jun;28:24-30. doi: 10.1016/j.jocn.2015.11.014. Epub 2016 Jan 19.
7
Prognostic value of H3K27me3 in children with ependymoma.H3K27me3 在儿童室管膜瘤中的预后价值。
Pediatr Blood Cancer. 2020 Mar;67(3):e28121. doi: 10.1002/pbc.28121. Epub 2019 Dec 18.
8
An integrative analysis of treatment, outcomes and prognostic factors for primary spinal anaplastic ependymomas.原发性脊髓间变性室管膜瘤治疗、结局及预后因素的综合分析
J Clin Neurosci. 2015 Jun;22(6):976-80. doi: 10.1016/j.jocn.2014.11.032. Epub 2015 Mar 11.
9
[Prognostic factors and results after the combined surgical and radiotherapy treatment of ependymomas].[室管膜瘤手术联合放疗后的预后因素及结果]
Strahlenther Onkol. 1992 Dec;168(12):679-85.
10
Treatment of pediatric Grade II spinal ependymomas: a population-based study.儿童II级脊髓室管膜瘤的治疗:一项基于人群的研究。
J Neurosurg Pediatr. 2015 Mar;15(3):243-9. doi: 10.3171/2014.9.PEDS1473. Epub 2014 Dec 19.

引用本文的文献

1
Correlation Analysis of Imaging and Pathological Features of Ependymomas.室管膜瘤影像学与病理学特征的相关性分析
Int J Gen Med. 2025 Jul 21;18:4001-4009. doi: 10.2147/IJGM.S528992. eCollection 2025.
2
Optimizing outcomes in intracranial ependymoma: a contemporary review.优化颅内室管膜瘤的治疗结果:当代综述
Front Oncol. 2025 Jun 10;15:1617169. doi: 10.3389/fonc.2025.1617169. eCollection 2025.
3
Imaging of supratentorial ependymomas with radio-pathological correlation.幕上室管膜瘤的影像学表现及其与病理的相关性
Explor Target Antitumor Ther. 2024;5(3):766-779. doi: 10.37349/etat.2024.00245. Epub 2024 Jun 27.
4
Do We Need Radiotherapy in Grade II Ependymoma?二级室管膜瘤需要放疗吗?
Front Oncol. 2022 Mar 4;12:800505. doi: 10.3389/fonc.2022.800505. eCollection 2022.
5
Cerebellopontine angle ependymoma presenting as isolated hearing loss in an elderly patient: A case report and literature review.老年患者以孤立性听力损失为表现的桥小脑角室管膜瘤:一例报告及文献复习
Surg Neurol Int. 2021 Nov 23;12:572. doi: 10.25259/SNI_781_2021. eCollection 2021.
6
Ependymoma, NOS and anaplastic ependymoma incidence and survival in the United States varies widely by patient and clinical characteristics, 2000-2016.2000 - 2016年,美国NOS级室管膜瘤和间变性室管膜瘤的发病率及生存率因患者和临床特征的不同而有很大差异。
Neurooncol Pract. 2020 May 9;7(5):549-558. doi: 10.1093/nop/npaa023. eCollection 2020 Oct.
7
The effect of adjuvant radiotherapy on overall survival in adults with intracranial ependymoma.辅助放疗对成人颅内室管膜瘤总生存期的影响。
Neurooncol Pract. 2020 Jul;7(4):391-399. doi: 10.1093/nop/npz070. Epub 2019 Dec 19.
8
Comparison of epidemiology, treatments, and outcomes in pediatric versus adult ependymoma.儿童与成人室管膜瘤的流行病学、治疗方法及预后比较。
Neurooncol Adv. 2020 Feb 21;2(1):vdaa019. doi: 10.1093/noajnl/vdaa019. eCollection 2020 Jan-Dec.
9
World Health Organization Grade III Supratentorial Extraventricular Ependymomas in Adults: Case Series and Review of Treatment Modalities.世界卫生组织III级成人幕上脑室外室管膜瘤:病例系列及治疗方式综述
Asian J Neurosurg. 2019 Nov 25;14(4):1157-1164. doi: 10.4103/ajns.AJNS_239_18. eCollection 2019 Oct-Dec.
10
Found at Old Age and Continuously Growing WHO Grade II Fourth Ventricle Ependymoma: A Case Report.老年发现且持续生长的WHO二级第四脑室室管膜瘤:一例报告
Brain Tumor Res Treat. 2019 Oct;7(2):141-146. doi: 10.14791/btrt.2019.7.e32.

本文引用的文献

1
Adult ependymal tumors: prognosis and the M. D. Anderson Cancer Center experience.成人室管膜瘤:预后和 M.D.安德森癌症中心的经验。
Neuro Oncol. 2010 Aug;12(8):862-70. doi: 10.1093/neuonc/noq009. Epub 2010 Feb 5.
2
Adult intracranial WHO grade II ependymomas: long-term outcome and prognostic factor analysis in a series of 114 patients.成人颅内世界卫生组织分级 II 级室管膜瘤:114 例患者系列的长期结果和预后因素分析。
Neuro Oncol. 2010 Sep;12(9):976-84. doi: 10.1093/neuonc/noq047. Epub 2010 May 19.
3
Ependymomas in adults.成人室管膜瘤。
Curr Neurol Neurosci Rep. 2010 May;10(3):240-7. doi: 10.1007/s11910-010-0109-3.
4
Ependymoma in adults: surgery, reoperation and radiotherapy for survival.成人室管膜瘤:为生存而行的手术、再次手术和放疗。
Pathol Oncol Res. 2010 Mar;16(1):93-9. doi: 10.1007/s12253-009-9194-5. Epub 2009 Aug 30.
5
Outcomes of malignant CNS ependymomas: an examination of 2408 cases through the Surveillance, Epidemiology, and End Results (SEER) database (1973-2005).恶性中枢神经系统室管膜瘤的预后:通过监测、流行病学和最终结果(SEER)数据库(1973 - 2005年)对2408例病例的研究。
J Surg Res. 2009 Oct;156(2):340-51. doi: 10.1016/j.jss.2009.04.024. Epub 2009 May 14.
6
Incidence patterns for ependymoma: a surveillance, epidemiology, and end results study.室管膜瘤的发病模式:一项监测、流行病学及最终结果研究。
J Neurosurg. 2009 Apr;110(4):725-9. doi: 10.3171/2008.9.JNS08117.
7
Cancer survivorship and aging.癌症幸存者与衰老
Cancer. 2008 Dec 15;113(12 Suppl):3519-29. doi: 10.1002/cncr.23941.
8
Cancer survivorship and aging : moving the science forward.癌症幸存者与衰老:推动科学进步
Cancer. 2008 Dec 15;113(12 Suppl):3530-9. doi: 10.1002/cncr.23942.
9
Supratentorial ependymomas: prognostic factors and outcome analysis in a retrospective series of 46 adult patients.幕上室管膜瘤:46例成年患者回顾性系列研究中的预后因素及结果分析
Cancer. 2008 Jul 1;113(1):175-85. doi: 10.1002/cncr.23530.
10
Breast cancer in the elderly.老年乳腺癌
J Clin Oncol. 2007 May 10;25(14):1882-90. doi: 10.1200/JCO.2006.10.2079.

老年人室管膜瘤患者的生存预测因素。

Predictors of survival among older adults with ependymoma.

机构信息

Dan L Duncan Cancer Center, Baylor College of Medicine, One Baylor Plaza, MS:BCM305, Houston, TX 77030, USA.

出版信息

J Neurooncol. 2012 Mar;107(1):183-9. doi: 10.1007/s11060-011-0730-2. Epub 2011 Sep 28.

DOI:10.1007/s11060-011-0730-2
PMID:21952907
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3863332/
Abstract

The biological process of aging encompasses a multitude of complex physiological and lifestyle changes that may alter the way typical prognostic factors affect survival among older ependymoma patients. Because very little is known about the clinical significance of traditional prognostic factors and the magnitude of their effects among older individuals, the purpose of this study was to evaluate the associations between survival and demographic and tumor characteristics among patients with ependymoma who were 60 years of age or older. Using the 1973-2007 dataset from the Surveillance, Epidemiology and End Results (SEER) program, we evaluated the impact of several factors on both overall and ependymoma-specific survival, utilizing multivariable Cox proportional hazards regression. We identified 367 ependymoma cases who were 60 years of age or older at diagnosis and had complete data from SEER. Of these, 19 (5.2%) had anaplastic tumors; all others were low-grade tumors. Age, tumor site, extent of surgery, and tumor histology were found to be significant predictors of ependymoma prognosis. The strongest predictor of poor outcome was supratentorial tumor location (adjusted HR: 6.94, 95% CI: 3.19-15.08, compared to spinal cord tumors). Our study suggests that tumor location, tumor histology, and surgical margin may be key predictors of survival among older ependymoma patients. We believe our study is one of the first to assess the prognostic value of these factors for ependymoma survival exclusively in an older patient population.

摘要

衰老的生物学过程包含了许多复杂的生理和生活方式变化,这些变化可能会改变典型预后因素影响老年室管膜瘤患者生存的方式。由于人们对传统预后因素的临床意义及其在老年人中的影响程度知之甚少,因此本研究旨在评估生存与年龄在 60 岁及以上的室管膜瘤患者的人口统计学和肿瘤特征之间的关系。我们利用 1973-2007 年监测、流行病学和最终结果 (SEER) 计划中的数据集,利用多变量 Cox 比例风险回归评估了几种因素对总体和室管膜瘤特异性生存的影响。我们确定了 367 例年龄在 60 岁及以上且具有 SEER 完整数据的室管膜瘤病例。其中,19 例(5.2%)为间变型肿瘤;其余均为低级别肿瘤。年龄、肿瘤部位、手术范围和肿瘤组织学被认为是室管膜瘤预后的重要预测因素。预后不良的最强预测因素是幕上肿瘤部位(调整后的 HR:6.94,95%CI:3.19-15.08,与脊髓肿瘤相比)。我们的研究表明,肿瘤位置、肿瘤组织学和手术切缘可能是老年室管膜瘤患者生存的关键预测因素。我们相信我们的研究是首次在老年患者群体中专门评估这些因素对室管膜瘤生存预后价值的研究之一。